Amit G. Pandya, MD
Melasma is a pigmentary disorder of the skin which appears as brown patches on the face
of adults. Both sides of the face, especially the cheeks, bridge of nose, forehead, and
upper lip, are involved. Some patients may have mild involvement in just a few of the
above areas. This condition is very common, particularly those with darker skin types.
Who does melasma affect?
Melasma predominantly occurs in people with skin of color, and 90% are women.
Latin- America, Asia, Middle East, and Northern Africa are areas with a higher
prevalence of melasma. Patients with brown skin, particularly in areas of high sun
exposure, are especially susceptible to getting melasma.
What is the cause of melasma?
Although the exact cause of melasma is unknown, affected people often have a
family history of melasma. In addition, a change in hormonal status, particularly
pregnancy and birth control pills, are commonly associated with melasma, and melasma
is often referred to as the “mask of pregnancy”. Post-menopausal hormone replacement
therapy has not been shown to cause melasma.
Sun and light exposure are some of the most common reasons for the appearance
of melasma. Ultraviolet light from the sun and visible light from light bulbs can stimulate
pigment-producing cells in the skin called melanocytes to produce more pigment.
Melanocytes are particularly active in those with brown or black skin. Even small
amounts of light exposure, such as driving in a car or walking in a parking lot to a store
can induce melasma and may account for the long duration of this condition in many
people. Irritation of the skin can produce a brown color as it heals, and any irritation of
the face in those with melasma may cause it to worsen. Although melasma can cause
significant brown staining of the skin as well as psychological stress and a negative
impact on quality of life, it is localized only to the skin and is not associated with any
internal diseases or organ malfunction.
How do I know if I have melasma?
Because of its characteristic appearance, melasma can usually be easily diagnosed
by a dermatologist with a skin examination. Biopsy of the skin may be sometimes
necessary in order to differentiate melasma from other conditions.
What are the best treatments for melasma?
Several treatments are available for melasma, but none work in every patient.
While some patients have melasma only for a few weeks or months, many have it for
years or decades. Pregnancy-associated melasma usually resolves within a few months
after delivery, although women in sunny climates may have persistence of the
pigmentation for many years. Because the sun and lighting are major causes of melasma,
sunscreens are very important in any treatment plan. Broad spectrum sunscreens, which
protect against UVA and UVB ultraviolet light should be used. A physical block, such as
zinc oxide and titanium oxide, may be used on top of chemical sunscreens to block light
even more. Daily use of sunscreens is important, since even small doses of light can
worsen melasma. Visors and tinting can protect from ultraviolet light while driving.
Oral contraceptive pills may need to be discontinued if they cause melasma.
Irritating creams or makeup should be stopped, and the skin should be treated as gently as
While many bleaching creams are available for the treatment of melasma, these
agents do not actually “bleach” the skin by destroying the melanocytes, but reduce their
activity. Hydroquinone is the most commonly used depigmenting agent and is available
in low strengths over the counter and in higher strengths through prescription from a
physician. Hydroquinone is the most effective of all the depigmenting agents, and takes
3-6 months to reach maximum results. Combination creams containing tretinoin, steroids,
and glycolic acid along with hydroquinone enhance its depigmenting effect. Azelaic acid
and kogic acid are two other agents that have depigmenting effects and are effective for
many patients. Several over the counter natural products are available to bleach the skin
and may be effective for mild cases of melasma. Various procedures, including chemical
peels, microdermabrasion, and laser surgery have been used in patients with melasma,
but results so far have not been consistent. Procedures like these, which remove layers of
the skin, have the potential of causing significant irritation, which can worsen melasma.
If done properly, however, these procedures may produce some benefit in selected
patients. Generally, these procedures should be performed with great care by those who
are familiar with their use in patients with skin of color.
In summary, while melasma can be a persistent, frustrating and difficult skin disorder, a
comprehensive management approach, including avoidance of sun and irritants, use of
sunscreens, depigmenting agents, occasional procedures, and close supervision by your
dermatologist can lead to a successful outcome.
Search Results for : melasma
Melasma Amit G. Pandya, MD Melasma is a pigmentary disorder of the skin which appears as brown patches on the face of adults. Both sides of the face, especially the cheeks, bridge of nose, forehead, and upper lip, are involved. Some patients may have mild involvement in just a few of the above areas. This…
Observership Experience: A Closer Look
The Skin of Color Society Observership Program offers young physicians and scientists a unique and highly valuable opportunity to learn directly from SOCS mentors, enabling them to acquire academic and/or research skills that will further their careers as future leaders in skin of color dermatology. This exciting and meaningful program is open to medical students…
Approaching 15 Years of Supporting Scientific Trailblazers through Skin of Color Society Grant Awards
As you may have seen from recent member communiqués in your email inbox and on our SOCS social media platforms, we are currently in the height of “open season” for applications for some exciting opportunities for SOCS members that help support and advance skin of color dermatology research and career development.(Details about both of…
Valerie M. Harvey, MD, MPH, FAAD
Valerie M. Harvey, MD, MPH, FAAD, earned her undergraduate and medical degrees from the University of Virginia. She completed her residency and Chief Residency at the University of Maryland Medical Center. She later received a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health. Dr. Harvey is a Fellow of the…
Enhanced Patient Education Resources on the SOCS Website
We are pleased to offer a wide variety of patient educational resources on the Skin of Color Society (SOCS) website, now available in English and Spanish translations! Thanks to expert contributions from many SOCS members, the Patient Dermatology Education section of the site features informative articles to help patients of color better understand the following dermatologic…
Experiences of some of our SOCS Observership Grant Recipients Mentee: Autumn Saizan, BS Mentor: Nada Elbuluk, MD, MSc Keck School of Medicine at University of Southern California 2021 Observership Award During the 2021-2022 academic year, I completed the Skin of Color and Pigmentary Disorders Research Fellowship at the Keck School of Medicine of the University…
17th Annual Skin of Color Society
Virtual Scientific Symposium Recap
Our recent 17th Annual Skin of Color Society Virtual Scientific Symposium was a tremendous success on many levels, with thanks and congratulations to many SOCS members and supporters for their contributions to help make this superb program possible. We begin our recap by heartily congratulating and thanking SOCS Scientific Committee co-chairs, Amy McMichael, MD, FAAD…
Nada Elbuluk, MD, MSc, FAAD
Dr. Nada Elbuluk is a board-certified dermatologist and Assistant Professor at the USC Keck School of Medicine, Department of Dermatology. She is honored to be a dermatologist at USC and to be able to serve the diverse population of Los Angeles. She is the founder and director of the USC Skin of Color Center and…
A Record-Setting Year of Diversity in Action for the Skin of Color Society Including SOCS activities since the Diversity Champion Workshop Co-hosted by The American Academy of Dermatology, the Association of Professors of Dermatology, the Society for Investigative Dermatology, and the Women's Dermatologic Society, SOCS leaders joined other dermatology faculty champions to discuss dermatology diversity…
The Skin of Color Society, New England Journal of Medicine Group and VisualDX Collaboration: The Impact of Skin Color and Ethnicity on Clinical Diagnosis and Research
We are thrilled to be a part of a groundbreaking virtual series in collaboration with the New England Journal of Medicine Group (NEJM Group) and VisualDx, which brings together Skin of Color Society experts, thought leaders and other advocates in collaborative discussions addressing issues of health disparities, structural racism and medicine, while examining specific dermatologic…
Click here for more information on the Valeant Research Award.
Read published peer-reviewed articles written your by Skin of Color Society members
Did You Know
Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.
By 2042, more than 50% of the US population will have skin of color.